Biomedical Engineering Reference
In-Depth Information
44. Maltais F, Leblanc P, Simard C, Jobin J, B´rub´ C, Bruneau J, et al. Skeletal
muscle adaptation to endurance training in patients with chronic obstructive
pulmonary disease. Am J Respir Crit Care Med 1996; 154(2):442-447.
45. Maltais F, Leblanc P, Jobin J, B
´
rub
´
C, Bruneau J, Carrier L, et al. Intensity
of training and physiologic adaptation in patients with chronic obstructive
pulmonary disease. Am J Respir Crit Care Med 1997; 155(2):555-561.
46. Sala E, Roca J, Marrades RM, Alonso J, Gonzalez de Suso JM, Moreno A, et
al. Effects of endurance training on skeletal muscle bioenergetics in chronic
obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159:
1726-1734.
47. Sauleda J, Garcia-Palmer FJ, Wiesner R, Tarraga S, Harting I, Tomas P, et al.
Cytochrome oxidase activity and mitochondrial gene expression in skeletal
muscle of patients with chronic obstructive pulmonary disease. Am J Respir
Crit Care Med 1998; 157(5):1413-1417.
48. Engelen MP, Wouters EF, Deutz NE, Does JD, Schols AM. Effects of exer-
cise on amino acid metabolism in patients with chronic obstructive pulmonary
disease. Am J Respir Crit Care Med 2001; 163(4):859-864.
49. Engelen MP, Schols AM, Does JD, Gosker HR, Deutz NE, Wouters EF.
Exercise-induced lactate increase in relation to muscle substrates in patients
with chronic obstructive pulmonary disease. Am J Respir Crit Care Med
2000; 162(5):1697-1704.
50. Schols AM, Wouters EF. Nutritional abnormalities and supplementation in
chronic obstructive pulmonary disease. Clin Chest Med 2000; 21(4):753-762.
51. Baarends EM, Schols AMWJ, Slebos DJ, Mostert R, Janssen PP, Wouters
EFM. Metabolic and ventilatory response pattern to arm elevation in patients
with COPD and healthy age-matched subjects. Eur Respir J 1995; 8:
1345-1351.
52. Amoroso P, Wilson SR, Moxham J, Ponte J. Acute effects of inhaled
salbutamol on the metabolic rate of normal subjects. Thorax 1993; 48:
882-885.
53. Bigard AX, Sanchez H, Birot O, Serrurier B. Myosin heavy chain composition
of skeletal muscles in young rats growing under hypobaric hypoxia conditions.
J Appl Physiol 2000; 88(2):479-486.
54. Rennie MJ, Edwards RH, Emery PW, Halliday D, Lundholm K, Millward
DJ. Depressed protein synthesis is the dominant characteristic of muscle wast-
ing and cachexia. Clin Physiol 1983; 3(5):387-398.
55. Green HJ, Sutton JR, Cymerman A, Houston CS. Operation Everest II: adap-
tations in human skeletal muscle. J Appl Physiol 1989; 66:2454-2461.
56. Bigard AX, Brunet A, Guezennec CY, Monod H. Skeletal muscle changes
after endurance training at high altitude. J Appl Physiol 1991; 71:2114-2121.
57. Hughes RL, Katz H, Sahgal V, Campbell JA, Hartz R, Shields TW. Fiber size
and energy metabolites in five separate muscles from patients with chronic
obstructive lung disease. Respiration 1983; 44:321-328.
58.
Jakobsson P, Jorfeldt L, Brundin A. Skeletal muscle metabolites and fibre
types in patients with advanced chronic obstructive pulmonary disease
(COPD), with and without chronic respiratory failure. Eur Respir J 1990;
3:192-196.
